J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.